Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.72M | 37.03M | 1.01M | -8.23M | -15.88M |
| Total Depreciation and Amortization | 24.19M | 18.60M | 18.18M | 17.71M | 17.34M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.98M | 66.44M | 37.51M | 36.80M | 51.88M |
| Change in Net Operating Assets | -41.14M | -132.38M | -95.49M | -79.46M | -48.90M |
| Cash from Operations | 30.75M | -10.31M | -38.79M | -33.18M | 4.44M |
| Capital Expenditure | -13.67M | -14.15M | -12.86M | -13.19M | -11.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.67M | -14.15M | -12.86M | -13.19M | -11.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.73M | -1.17M | -63.49M | -64.88M | -66.26M |
| Issuance of Common Stock | 132.00K | 157.00K | 1.22M | 1.09M | 1.09M |
| Repurchase of Common Stock | -3.14M | -1.89M | -27.28M | -27.28M | -27.33M |
| Issuance of Preferred Stock | -- | -- | 120.69M | 120.69M | 120.69M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.78M | -14.46M | -10.04M | -- | -- |
| Cash from Financing | -35.52M | -17.36M | 21.10M | 29.63M | 28.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.44M | -41.82M | -30.55M | -16.74M | 21.19M |